Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA May Create Immunology, Neuroscience Centers Of Excellence

Executive Summary

Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.

Advertisement

Related Content

US FDA Drug Office Reform: 'Everything' Is On The Table
FDA's Budget Flat In House Bill, But Path For 'Cures' Funding Cleared
FDA Tussles With Combination Products, Fires Up Oncology Center Of Excellence
US FDA Still Waiting For Cures Money, Woodcock Says
Combo Product Review Pilot At US FDA Will Offer All Applications Intercenter Consults
Multiple ‘Centers of Excellence’ At US FDA Could Create Review Inefficiencies – Jenkins
Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?
FDA's Pazdur Jumps Over To New 'Moonshot' Role
FDA 'Intercenter Institutes' Legislation Headed For Senate Mark-Up
Don't Rush To Reorganize FDA, McClellan Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS122065

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel